Scorpion Therapeutics Stock
Scorpion Therapeutics aims to reshape cancer treatment with itsPrecision Oncology 2.0 approach. This strategy focuses on three key areas: targeting known, underserved cancer drivers, drugging previously undruggable targets, and discovering novel targets with high therapeutic potential.
Management Team
| Adam Friedman, MD, Ph.D. CEO |
| Mark Chao, MD, Ph.D. Chief Medical Officer |
| Erica L. Jackson, Ph.D. Chief Discovery Officer |
| Brian Piper CFO |
| Kristin Schuhwerk COO |
| Darrin Stuart, Ph.D. Chief Scientific Officer |
| Amanda Valentino Chief People Officer |
